Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intrexon Corp (NYSE:XON)

28.28
Delayed Data
As of 4:02pm ET
 +0.44 / +1.58%
Today’s Change
18.52
Today|||52-Week Range
40.24
-6.20%
Year-to-Date
Intrexon Corporation Surged 12% in November -- Here's Why
9:24am / MotleyFool.com - Paid Partner Content
Oragenics Jumps on Fast Track Status for Oral Mucositis Drug
Nov 23 / Zacks.com - Paid Partner Content
Retail, Financials, Speculative Biotechs Getting Hit
Nov 28 / TheStreet.com - Paid Partner Content
3 Reasons Intrexon Corp. Stock Could Fall
Nov 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close27.84
Today’s open27.95
Day’s range27.59 - 29.00
Volume1,015,997
Average volume (3 months)1,355,860
Market cap$3.3B
Dividend yield--
Data as of 4:02pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+8.43%
Earnings growth (this year)-97.59%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+141.35%
P/E ratioNM
Price/Sales19.29
Price/Book4.68

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+0.01+0.02%
TECHBio-Techne Corp-0.47-0.44%
BLUEbluebird bio Inc+1.10+1.60%
ARIAARIAD Pharmaceutical...+0.09+0.69%
Data as of 4:14pm ET, 12/02/2016

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$173.6M
Annual profit (last year)-$84.5M
Net profit margin-48.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Randal J. Kirk
President
Geno J. Germano
Corporate headquarters
Germantown, Maryland

Forecasts


Search for Jobs